Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Entinostat

EU orphan designation number: EU/3/10/732   
Active ingredient: Entinostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Syndax Limited
The Clock House, Station Approach, Marlow, Buckinghamshire SL7 1NT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/06/2010 Orphan designation EMEA/OD/150/09 (2010)3901 of 10/06/2010
12/02/2013 Change of name and/or address of sponsor
28/04/2015 Transfer of orphan designation EMA/OD/150/09/T/01 (2015)2953 of 24/04/2015